Possible Markers for Distinguishing benign and Malignant Thyroid Tumors and Predicting Malignancy in Patients with Genetic Predisposition to Cancer

Possible Markers for Distinguishing benign and Malignant Thyroid Tumors and Predicting Malignancy in Patients with Genetic Predisposition to Cancer

We hypothesized that mutations in several genes disrupt oxidative metabolism, increasing the risk of developing tumors and their malignancy in patients with a family predisposition to cancer. The purpose of our study was to assess the characteristics of oxidative metabolism in patients with malignan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Asian Pacific Journal of Cancer Prevention 2024-02, Vol.25 (2), p.465-472
Hauptverfasser: Javakhishvili, Ivane, Mardaleishvili, Konstantine, Mantskava, Maia, Shekiladze, Eka, Tortladze, Magda, Kalmakhelidze, Sophio, Sanikidze, Tamar
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 472
container_issue 2
container_start_page 465
container_title Asian Pacific Journal of Cancer Prevention
container_volume 25
creator Javakhishvili, Ivane
Mardaleishvili, Konstantine
Mantskava, Maia
Shekiladze, Eka
Tortladze, Magda
Kalmakhelidze, Sophio
Sanikidze, Tamar
description We hypothesized that mutations in several genes disrupt oxidative metabolism, increasing the risk of developing tumors and their malignancy in patients with a family predisposition to cancer. The purpose of our study was to assess the characteristics of oxidative metabolism in patients with malignant and benign tumor with and without a family history of cancer and identify the marker predicting the likelihood of malignancy. We conducted a study on patients with thyroid pathology (thyrotoxicosis, benign tumor pathology of the thyroid gland, and thyroid cancer) who underwent treatment at LLC "Oncology Scientific Research Center" in Tbilisi, Georgia between 2020-2021.  In patients' blood the thyroid hormones content, the oxidative metabolism parameters (activity of nonenzymatic antioxidant system (TAA), malondialdehyde (MDA) content),  geometrical and rheological (deformability index (EDI), membrane proteins content) characteristics of erythrocytes were determined. in the patient's blood serum with benign tumor (47 patients) MDA exceeded (p
doi_str_mv 10.31557/APJCP.2024.25.2.465
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11077121</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>38415532</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2735-ed818bd548c40e693ffffe0ff6dab222e2a8b05fbecaf1f83122c52defd8a3a93</originalsourceid><addsrcrecordid>eNpVkdFOGzEQRa2qqFDoH1SVfyBbe7zeXZ4QSlsKAnUfUok3y2uPE5fEjuxNq3xHfxiHQATzMiPNPdfWXEI-c1YJLmX79bK_mfYVMKgrkBVUdSPfkROo22bSNnD__tV8TD7m_IexWnat_ECORVcXCwEn5H8fc_bDEumdTg-YMnUx0W8-jz7MNz4vSqMDBj8PVAdbVMsy6jDS2WKbord0tlnFgu2WfULrzY486MyW-kB7PXoMY6b__LigVxhw9GYvz-uY_ehjoGOk0wJgOiNHTi8zfnrup-T3j--z6c_J7a-r6-nl7cRAK-QEbce7wcq6MzXD5ly4Usica6weAABBdwOTbkCjHXed4ABGgkVnOy30uTglF3vf9WZYoTXlh0kv1Tr5lU5bFbVXbzfBL9Q8_lWcs7blwItDvXcwqZwxoTvAnKmnlNRTSmqXkgKpQJWUCvbl9cMH6CUW8Qiv3JTD</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Possible Markers for Distinguishing benign and Malignant Thyroid Tumors and Predicting Malignancy in Patients with Genetic Predisposition to Cancer</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free E- Journals</source><creator>Javakhishvili, Ivane ; Mardaleishvili, Konstantine ; Mantskava, Maia ; Shekiladze, Eka ; Tortladze, Magda ; Kalmakhelidze, Sophio ; Sanikidze, Tamar</creator><creatorcontrib>Javakhishvili, Ivane ; Mardaleishvili, Konstantine ; Mantskava, Maia ; Shekiladze, Eka ; Tortladze, Magda ; Kalmakhelidze, Sophio ; Sanikidze, Tamar</creatorcontrib><description><![CDATA[We hypothesized that mutations in several genes disrupt oxidative metabolism, increasing the risk of developing tumors and their malignancy in patients with a family predisposition to cancer. The purpose of our study was to assess the characteristics of oxidative metabolism in patients with malignant and benign tumor with and without a family history of cancer and identify the marker predicting the likelihood of malignancy. We conducted a study on patients with thyroid pathology (thyrotoxicosis, benign tumor pathology of the thyroid gland, and thyroid cancer) who underwent treatment at LLC "Oncology Scientific Research Center" in Tbilisi, Georgia between 2020-2021.  In patients' blood the thyroid hormones content, the oxidative metabolism parameters (activity of nonenzymatic antioxidant system (TAA), malondialdehyde (MDA) content),  geometrical and rheological (deformability index (EDI), membrane proteins content) characteristics of erythrocytes were determined. in the patient's blood serum with benign tumor (47 patients) MDA exceeded (p<0.005) and TAA decreased (p<0.005) in comparison to the control level; in patients with thyroid cancer (35 patients), MDA also exceeded (p<0.005), while TAA increased (p<0.005) up to the control level. In patients with benign and malignant tumors, the size of erythrocytes increased compared to the control indicators (p<0.005); in patients with thyroid cancer and benign tumors with a family history of cancer (29 patients) EDI increased (p<0.005), content of GLUT1 in erythrocyte membranes decreased (p<0.005) compared to the control level. Alterations in redox metabolism play a crucial role in tumor formation; an imbalance between anti-/pro-oxidant systems may contribute to tumor formation and support its progression into a more malignant state. Thyroid cancer is characterized by a reduction in erythrocyte deformability, related to TSH levels. These alterations are less detectable in patients with benign thyroid tumors with a family history of cancer.]]></description><identifier>ISSN: 2476-762X</identifier><identifier>ISSN: 1513-7368</identifier><identifier>EISSN: 2476-762X</identifier><identifier>DOI: 10.31557/APJCP.2024.25.2.465</identifier><identifier>PMID: 38415532</identifier><language>eng</language><publisher>Thailand: West Asia Organization for Cancer Prevention</publisher><ispartof>Asian Pacific Journal of Cancer Prevention, 2024-02, Vol.25 (2), p.465-472</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-6507-5746</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11077121/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11077121/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38415532$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Javakhishvili, Ivane</creatorcontrib><creatorcontrib>Mardaleishvili, Konstantine</creatorcontrib><creatorcontrib>Mantskava, Maia</creatorcontrib><creatorcontrib>Shekiladze, Eka</creatorcontrib><creatorcontrib>Tortladze, Magda</creatorcontrib><creatorcontrib>Kalmakhelidze, Sophio</creatorcontrib><creatorcontrib>Sanikidze, Tamar</creatorcontrib><title>Possible Markers for Distinguishing benign and Malignant Thyroid Tumors and Predicting Malignancy in Patients with Genetic Predisposition to Cancer</title><title>Asian Pacific Journal of Cancer Prevention</title><addtitle>Asian Pac J Cancer Prev</addtitle><description><![CDATA[We hypothesized that mutations in several genes disrupt oxidative metabolism, increasing the risk of developing tumors and their malignancy in patients with a family predisposition to cancer. The purpose of our study was to assess the characteristics of oxidative metabolism in patients with malignant and benign tumor with and without a family history of cancer and identify the marker predicting the likelihood of malignancy. We conducted a study on patients with thyroid pathology (thyrotoxicosis, benign tumor pathology of the thyroid gland, and thyroid cancer) who underwent treatment at LLC "Oncology Scientific Research Center" in Tbilisi, Georgia between 2020-2021.  In patients' blood the thyroid hormones content, the oxidative metabolism parameters (activity of nonenzymatic antioxidant system (TAA), malondialdehyde (MDA) content),  geometrical and rheological (deformability index (EDI), membrane proteins content) characteristics of erythrocytes were determined. in the patient's blood serum with benign tumor (47 patients) MDA exceeded (p<0.005) and TAA decreased (p<0.005) in comparison to the control level; in patients with thyroid cancer (35 patients), MDA also exceeded (p<0.005), while TAA increased (p<0.005) up to the control level. In patients with benign and malignant tumors, the size of erythrocytes increased compared to the control indicators (p<0.005); in patients with thyroid cancer and benign tumors with a family history of cancer (29 patients) EDI increased (p<0.005), content of GLUT1 in erythrocyte membranes decreased (p<0.005) compared to the control level. Alterations in redox metabolism play a crucial role in tumor formation; an imbalance between anti-/pro-oxidant systems may contribute to tumor formation and support its progression into a more malignant state. Thyroid cancer is characterized by a reduction in erythrocyte deformability, related to TSH levels. These alterations are less detectable in patients with benign thyroid tumors with a family history of cancer.]]></description><issn>2476-762X</issn><issn>1513-7368</issn><issn>2476-762X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVkdFOGzEQRa2qqFDoH1SVfyBbe7zeXZ4QSlsKAnUfUok3y2uPE5fEjuxNq3xHfxiHQATzMiPNPdfWXEI-c1YJLmX79bK_mfYVMKgrkBVUdSPfkROo22bSNnD__tV8TD7m_IexWnat_ECORVcXCwEn5H8fc_bDEumdTg-YMnUx0W8-jz7MNz4vSqMDBj8PVAdbVMsy6jDS2WKbord0tlnFgu2WfULrzY486MyW-kB7PXoMY6b__LigVxhw9GYvz-uY_ehjoGOk0wJgOiNHTi8zfnrup-T3j--z6c_J7a-r6-nl7cRAK-QEbce7wcq6MzXD5ly4Usica6weAABBdwOTbkCjHXed4ABGgkVnOy30uTglF3vf9WZYoTXlh0kv1Tr5lU5bFbVXbzfBL9Q8_lWcs7blwItDvXcwqZwxoTvAnKmnlNRTSmqXkgKpQJWUCvbl9cMH6CUW8Qiv3JTD</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Javakhishvili, Ivane</creator><creator>Mardaleishvili, Konstantine</creator><creator>Mantskava, Maia</creator><creator>Shekiladze, Eka</creator><creator>Tortladze, Magda</creator><creator>Kalmakhelidze, Sophio</creator><creator>Sanikidze, Tamar</creator><general>West Asia Organization for Cancer Prevention</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6507-5746</orcidid></search><sort><creationdate>20240201</creationdate><title>Possible Markers for Distinguishing benign and Malignant Thyroid Tumors and Predicting Malignancy in Patients with Genetic Predisposition to Cancer</title><author>Javakhishvili, Ivane ; Mardaleishvili, Konstantine ; Mantskava, Maia ; Shekiladze, Eka ; Tortladze, Magda ; Kalmakhelidze, Sophio ; Sanikidze, Tamar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2735-ed818bd548c40e693ffffe0ff6dab222e2a8b05fbecaf1f83122c52defd8a3a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Javakhishvili, Ivane</creatorcontrib><creatorcontrib>Mardaleishvili, Konstantine</creatorcontrib><creatorcontrib>Mantskava, Maia</creatorcontrib><creatorcontrib>Shekiladze, Eka</creatorcontrib><creatorcontrib>Tortladze, Magda</creatorcontrib><creatorcontrib>Kalmakhelidze, Sophio</creatorcontrib><creatorcontrib>Sanikidze, Tamar</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Asian Pacific Journal of Cancer Prevention</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Javakhishvili, Ivane</au><au>Mardaleishvili, Konstantine</au><au>Mantskava, Maia</au><au>Shekiladze, Eka</au><au>Tortladze, Magda</au><au>Kalmakhelidze, Sophio</au><au>Sanikidze, Tamar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Possible Markers for Distinguishing benign and Malignant Thyroid Tumors and Predicting Malignancy in Patients with Genetic Predisposition to Cancer</atitle><jtitle>Asian Pacific Journal of Cancer Prevention</jtitle><addtitle>Asian Pac J Cancer Prev</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>25</volume><issue>2</issue><spage>465</spage><epage>472</epage><pages>465-472</pages><issn>2476-762X</issn><issn>1513-7368</issn><eissn>2476-762X</eissn><abstract><![CDATA[We hypothesized that mutations in several genes disrupt oxidative metabolism, increasing the risk of developing tumors and their malignancy in patients with a family predisposition to cancer. The purpose of our study was to assess the characteristics of oxidative metabolism in patients with malignant and benign tumor with and without a family history of cancer and identify the marker predicting the likelihood of malignancy. We conducted a study on patients with thyroid pathology (thyrotoxicosis, benign tumor pathology of the thyroid gland, and thyroid cancer) who underwent treatment at LLC "Oncology Scientific Research Center" in Tbilisi, Georgia between 2020-2021.  In patients' blood the thyroid hormones content, the oxidative metabolism parameters (activity of nonenzymatic antioxidant system (TAA), malondialdehyde (MDA) content),  geometrical and rheological (deformability index (EDI), membrane proteins content) characteristics of erythrocytes were determined. in the patient's blood serum with benign tumor (47 patients) MDA exceeded (p<0.005) and TAA decreased (p<0.005) in comparison to the control level; in patients with thyroid cancer (35 patients), MDA also exceeded (p<0.005), while TAA increased (p<0.005) up to the control level. In patients with benign and malignant tumors, the size of erythrocytes increased compared to the control indicators (p<0.005); in patients with thyroid cancer and benign tumors with a family history of cancer (29 patients) EDI increased (p<0.005), content of GLUT1 in erythrocyte membranes decreased (p<0.005) compared to the control level. Alterations in redox metabolism play a crucial role in tumor formation; an imbalance between anti-/pro-oxidant systems may contribute to tumor formation and support its progression into a more malignant state. Thyroid cancer is characterized by a reduction in erythrocyte deformability, related to TSH levels. These alterations are less detectable in patients with benign thyroid tumors with a family history of cancer.]]></abstract><cop>Thailand</cop><pub>West Asia Organization for Cancer Prevention</pub><pmid>38415532</pmid><doi>10.31557/APJCP.2024.25.2.465</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-6507-5746</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2476-762X
ispartof Asian Pacific Journal of Cancer Prevention, 2024-02, Vol.25 (2), p.465-472
issn 2476-762X
1513-7368
2476-762X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11077121
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free E- Journals
title Possible Markers for Distinguishing benign and Malignant Thyroid Tumors and Predicting Malignancy in Patients with Genetic Predisposition to Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T06%3A13%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Possible%20Markers%20for%20Distinguishing%20benign%20and%20Malignant%20Thyroid%20Tumors%20and%20Predicting%20Malignancy%20in%20Patients%20with%20Genetic%20Predisposition%20to%20Cancer&rft.jtitle=Asian%20Pacific%20Journal%20of%20Cancer%20Prevention&rft.au=Javakhishvili,%20Ivane&rft.date=2024-02-01&rft.volume=25&rft.issue=2&rft.spage=465&rft.epage=472&rft.pages=465-472&rft.issn=2476-762X&rft.eissn=2476-762X&rft_id=info:doi/10.31557/APJCP.2024.25.2.465&rft_dat=%3Cpubmed_cross%3E38415532%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/38415532&rfr_iscdi=true